DORI, A.; GUGLIERI, M.; SCUTIFERO, M.; PASSAMANO, L.; TRABACCA, L.; POLITANO, L. Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up. Acta Myologica, [S. l.], v. 41, n. 1, 2022. Disponível em: https://www.actamyologica.it/article/view/435. Acesso em: 27 jul. 2024.